- Markets
- Healthcare
- LINKPH
LINKPH
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Link Pharmachem Purchased Plot In Vadodara From Chloro Chem Of India
March 6 (Reuters) - Link Pharmachem Ltd LIPC.BO:
LINK PHARMACHEM LTD - PURCHASED PLOT IN VADODARA FROM CHLORO CHEM OF INDIA
Source text for Eikon: ID:nBSE5s5vXD
Further company coverage: LIPC.BO
(([email protected];))
March 6 (Reuters) - Link Pharmachem Ltd LIPC.BO:
LINK PHARMACHEM LTD - PURCHASED PLOT IN VADODARA FROM CHLORO CHEM OF INDIA
Source text for Eikon: ID:nBSE5s5vXD
Further company coverage: LIPC.BO
(([email protected];))
Link Pharma Chem Names Sanjib Dutta As CFO
Nov 8 (Reuters) - Link Pharma Chem Limited LIPC.BO:
NAMES SANJIB DUTTA AS CFO
Source text for Eikon: ID:nBSE8nGlSK
Further company coverage: LIPC.BO
(([email protected];;))
Nov 8 (Reuters) - Link Pharma Chem Limited LIPC.BO:
NAMES SANJIB DUTTA AS CFO
Source text for Eikon: ID:nBSE8nGlSK
Further company coverage: LIPC.BO
(([email protected];;))
Link Pharma Chem Says Jayesh Pushpavadan Jani Resigns As CFO
Oct 31 (Reuters) - Link Pharma Chem Limited LIPC.BO:
JAYESH PUSHPAVADAN JANI RESIGNS AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nBSE543VF3
Further company coverage: LIPC.BO
(([email protected];))
Oct 31 (Reuters) - Link Pharma Chem Limited LIPC.BO:
JAYESH PUSHPAVADAN JANI RESIGNS AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nBSE543VF3
Further company coverage: LIPC.BO
(([email protected];))
Link Pharma Chem Reappoints Satish G. Thakur As Chairman
Sept 22 (Reuters) - Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM REAPPOINTS SATISH G. THAKUR AS CHAIRMAN
Source text for Eikon: ID:nBSE7nhNxD
Further company coverage: LIPC.BO
(([email protected];))
Sept 22 (Reuters) - Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM REAPPOINTS SATISH G. THAKUR AS CHAIRMAN
Source text for Eikon: ID:nBSE7nhNxD
Further company coverage: LIPC.BO
(([email protected];))
Link Pharma Chem Limited- Nandesari Plant Restarted
Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM LIMITED- NANDESARI PLANT RESTARTED
LINK PHARMA CHEM LIMITED- ORDER RECEIVED FROM GUJARAT POLLUTION CONTROL BOARD
Source text for Eikon: ID:nBSE59bwYz
Further company coverage: LIPC.BO
Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM LIMITED- NANDESARI PLANT RESTARTED
LINK PHARMA CHEM LIMITED- ORDER RECEIVED FROM GUJARAT POLLUTION CONTROL BOARD
Source text for Eikon: ID:nBSE59bwYz
Further company coverage: LIPC.BO
Link Pharma Chem Re-Appoints Rishikesh Thakur As MD
May 29 (Reuters) - Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM LIMITED - RE-APPOINTS RISHIKESH THAKUR AS MANAGING DIRECTOR
LINK PHARMA CHEM LIMITED - RE-APPOINTS SATISH G. THAKUR AS CHAIRMAN
Source text for Eikon: ID:nBSEHzg9Q
Further company coverage: LIPC.BO
(([email protected];;))
May 29 (Reuters) - Link Pharma Chem Limited LIPC.BO:
LINK PHARMA CHEM LIMITED - RE-APPOINTS RISHIKESH THAKUR AS MANAGING DIRECTOR
LINK PHARMA CHEM LIMITED - RE-APPOINTS SATISH G. THAKUR AS CHAIRMAN
Source text for Eikon: ID:nBSEHzg9Q
Further company coverage: LIPC.BO
(([email protected];;))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Link Pharma Chem do?
Link Pharma Chem Ltd specializes in the production of thionyl chloride and various inorganic chemical intermediates.
Who are the competitors of Link Pharma Chem?
Link Pharma Chem major competitors are Colinz Laboratories, Norris Medicines, Parmax Pharma, Venmax Drugs&Pharma, Saroja Pharma Ind, Emmessar Biotech&Nut, Desh Rakshak Aushdh. Market Cap of Link Pharma Chem is ₹16 Crs. While the median market cap of its peers are ₹17 Crs.
Is Link Pharma Chem financially stable compared to its competitors?
Link Pharma Chem seems to be less financially stable compared to its competitors. Altman Z score of Link Pharma Chem is 2.18 and is ranked 4 out of its 8 competitors.
Does Link Pharma Chem pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Link Pharma Chem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Link Pharma Chem allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Link Pharma Chem balance sheet?
Balance sheet of Link Pharma Chem is moderately strong, But short term working capital might become an issue for this company.
Is the profitablity of Link Pharma Chem improving?
No, profit is decreasing. The profit of Link Pharma Chem is -₹1.36 Crs for Mar 2024, ₹0.65 Crs for Mar 2023 and ₹1.88 Crs for Mar 2022
Is the debt of Link Pharma Chem increasing or decreasing?
The debt of Link Pharma Chem is decreasing. Latest debt of Link Pharma Chem is ₹6.38 Crs as of Sep-24. This is less than Mar-24 when it was ₹9.11 Crs.
Is Link Pharma Chem stock expensive?
Link Pharma Chem is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Link Pharma Chem is 0.0, while 3 year average PE is 20.07. Also latest EV/EBITDA of Link Pharma Chem is 17.58 while 3yr average is 9.05.
Has the share price of Link Pharma Chem grown faster than its competition?
Link Pharma Chem has given lower returns compared to its competitors. Link Pharma Chem has grown at ~-19.07% over the last 1yrs while peers have grown at a median rate of 45.0%
Is the promoter bullish about Link Pharma Chem?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Link Pharma Chem is 51.49% and last quarter promoter holding is 51.49%.
Are mutual funds buying/selling Link Pharma Chem?
The mutual fund holding of Link Pharma Chem is stable. The current mutual fund holding in Link Pharma Chem is 0.02% while previous quarter holding is 0.02%.